Live Breaking News & Updates on Alkermes

Stay informed with the latest breaking news from Alkermes on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Alkermes and stay connected to the pulse of your community

Buy Rating Affirmed for Alkermes on Promising ALKS 2680 Clinical Trial Results and Growth Potential

Goldman Sachs analyst Chris Shibutani has maintained their bullish stance on ALKS stock, giving a Buy rating yesterday. Chris Shibutani has giv...

Arcutis-biotherapeutics , Chris-shibutani , Goldman-sachs , Alkermes , Merck-company , Tipranks-premium ,

Alkermes plc (NASDAQ:ALKS) Receives Average Recommendation of "Moderate Buy" from Brokerages

Alkermes plc (NASDAQ:ALKS – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten analysts that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. The […]

United-states , Wellington , New-zealand-general- , New-zealand , Ireland , America , Piper-sandler , Christian-todd-nichols , Robertw-baird , Rafferty-asset-management , Securities-exchange-commission , Wellington-management-group

Moody Aldrich Partners LLC Purchases 12,496 Shares of Alkermes plc (NASDAQ:ALKS)

Moody Aldrich Partners LLC boosted its position in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 31.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,570 shares of the company’s stock after purchasing an additional 12,496 shares during […]

United-states , Ireland , Blackrock , Louth , Wellington , New-zealand-general- , New-zealand , America , Piper-sandler , Robertw-baird , Christian-todd-nichols , Moody-aldrich-partners

Moody Aldrich Partners LLC Grows Position in Alkermes plc (NASDAQ:ALKS)

Moody Aldrich Partners LLC lifted its stake in Alkermes plc (NASDAQ:ALKS – Free Report) by 31.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 52,570 shares of the company’s stock after buying an additional 12,496 shares during the quarter. Moody Aldrich Partners LLC’s holdings in Alkermes […]

Wellington , New-zealand-general- , New-zealand , United-states , Ireland , America , Christian-todd-nichols , Piper-sandler , Arrowstreet-capital-limited-partnership , Nasdaq , Alkermes , Moody-aldrich-partners

AACR: Mural debuts data for potential pipeline additions

AACR: Mural debuts data for potential pipeline additions
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Caroline-loew , Fierce-biotech-research , Alkermes , Merck-co , American-association-for-cancer-research , Mural-oncology , American-association , Cancer-research ,

Alkermes plc: Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia

Alkermes plc: Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dublin , Ireland , United-states , Massachusetts , Athlone , Westmeath , Waltham , Ohio , American , Ron-grunstein , Sandy-coombs , Gretchen-murphy

Form 8-K Alkermes plc. For: Apr 09

Form 8-K Alkermes plc. For: Apr 09
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dublin , Ireland , United-states , Connaught , Mayo , Washington , Davidj-gaffin , Alkermes , Securities-exchange , General-instruction , Securities-act

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dublin , Ireland , United-states , Massachusetts , Waltham , Ohio , Athlone , Westmeath , American , Ron-grunstein , Sandy-coombs , Gretchen-murphy

Delivering The Next Evolution In Immuno-Oncology

Delivering The Next Evolution In Immuno-Oncology
lifescienceleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lifescienceleader.com Daily Mail and Mail on Sunday newspapers.

Caroline-loew , Carolinej-loew , Alkermes , Mural-oncology , Culture-where-all-voices-are ,

Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says - Alkermes (NASDAQ:ALKS)

ALKS 2680 reports positive results in narcolepsy & idiopathic hypersomnia study. Statistically significant improvements in sleep latency were observed across all doses tested. Phase 2 study for NT2 patients is planned for 2nd half of 2024. Jefferies raises price target & probability of success for ALKS-2680.

Alkermes , Wakefulness-test , Narcolepsy-type , Idiopathic-hypersomnia ,